Case Disclosed

“Much Ado About Nothing:” NYC Withholds Information on Empty Internet Piping

April 12, 2017
By David Hoffman

If you ever want to ruin a party in NYC (and/or potentially start a riot), just say the names Time Warner, RCN, Verizon, etc. and watch the anger snowball.

Read more

The Exemption 7 Escape from Government Disclosure of Sensitive, Non-classified Information

April 12, 2017
By John Brinkerhoff

One of FOIA’s strongest exemptions is, unsurprisingly, for classified information.

Read more

Prospective Injunctions Under FOIA

March 9, 2017
By Yurij Melynk

Even for its strongest advocates and those who regularly exercise the rights it grants, the Freedom of Information Act is often reduced to its most-invoked provision: the obligation of federal agencies to produce specific records in response to requests.

Read more

The Risks of Trump's Proposal to Speed Up Drug Approvals

February 20, 2017
By Mark Doré

President Trump has signaled—often and recently—that he believes drug approval moves too slowly. Meeting with drug manufacturers at the White House on Jan. 31, Trump promised quick yes-or-no approval decisions on new drugs (and stressed the need for lower prices and U.S.-based manufacturing).

Read more